Skip to main content
Journal of Aerosol Medicine and Pulmonary Drug Delivery logoLink to Journal of Aerosol Medicine and Pulmonary Drug Delivery
. 2018 Apr 1;31(2):71–77. doi: 10.1089/jamp.2017.1418

Electronic Cigarettes: Exposure and Use Among Pediatric Populations

Joseph M Collaco 1,, Sharon A McGrath-Morrow 1
PMCID: PMC5915214  PMID: 29068754

Abstract

As an emerging inhalational exposure, electronic cigarettes (e-cigarettes) have rapidly gained public awareness with increasing use among adolescents and adults, leading to increased primary use by adolescents and increased secondhand exposure to emissions in infants, children, and adolescents. Although the long-term health risks for primary use and secondhand emission exposure are unknown, limited data from animal studies suggest that there is the potential for long-term lung injury and altered neurocognitive development in children with exposure to nicotine-containing aerosols. In this pediatric-focused review, we discuss the history of e-cigarettes, the demographics of adolescent users, effects on health, and current legislative efforts to protect infants, children, and adolescents from exposure.

Keywords: : adolescent, children, e-cigarette, electronic cigarette, exposure, infants, pediatric, secondhand

Electronic Cigarettes: Background and History

Electronic cigarettes (e-cigarettes) are designed to deliver vaporized nicotine (or non-nicotine)-containing solutions for absorption via the respiratory tract, when activated by the user manually or through inspiration. First-generation e-cigarettes were introduced in China in 2004, Europe in 2006, and the United States in 2007.(1) Although the main components of e-cigarettes include a cartridge (or tank) containing a solution that may contain nicotine, a heating element that vaporizes the solution, and an electric power source for the heating element, variations in these e-cigarette components can lead to differing experiences and exposures for the user.(2,3)

The original first-generation e-cigarettes are disposable and were designed to mimic the appearance of conventional cigarettes unlike later e-cigarettes.(4) Later, first-generation and second-generation devices incorporate refillable cartridges or tanks and rechargeable lithium batteries. Third-generation e-cigarettes (mechanical mods) include more features such as customizable electronics and variable voltage.(3) The next-generation e-cigarettes may include variable heating elements, temperature control, and reduced resistance (sub-ohm) atomizers.

In addition to the variability in performance properties seen between commercial e-cigarettes of the same brand,(5) customization of e-cigarettes using these features may lead to alterations in particle size, aerosolization, chemical degradation with heat, and aerosol volume delivered.(6) Differences in puff topography, which can vary significantly between naive and experienced users, can also influence systemic absorption of vapor constituents.(7,8)

E-cigarette solutions (E-liquid) generally contain a carrier agent(s), typically propylene glycol, vegetable glycerin, or a combination of the two. A higher percentage of propylene glycol may provide more intense flavor and a stronger “throat hit” or sensation, whereas a higher percentage of vegetable glycerin may enhance vapor production.(9) Solutions containing different concentrations of nicotine (0%–5.4%) are commercially available, but there may be significant variation in nicotine content (as much as 12%) within the same batch of the same brand of e-cigarettes,(10) and some e-cigarettes marketed as 0% nicotine may actually contain nicotine.(11) Finally, e-cigarette solutions may also contain added flavorings based on traditional tobacco blends, fruits, candy, cocktails, and menthol, some of which may be very appealing to adolescents.(12)

Thus, owing to the variability in the characteristics of the devices themselves, variation in solutions within and between brands, and the user topography, it has been difficult to study the effects of e-cigarettes on primary adolescent users, children of users, and infants who may have had in utero exposure.(6,13) In this review, we aim to describe the potential health effects within pediatric populations from this emerging exposure. We would also emphasize that both the technologies used to deliver nicotine and research into health effects of these delivery systems are rapidly progressing, and we expect additional data to confirm the harmful effects on exposed children and young adults.

Primary User Demographics Among U.S. Youth

E-cigarette use exceeded conventional cigarette use among youth in the United States for the first time in 2014, reflecting a shift toward nonconventional cigarette tobacco products.(14) Although current e-cigarette use (within the past 30 days) increased from 1.5% of high school students to 11.3% between 2011 and 2016, the percentage of high school students reporting current use in 2016 was actually a decrease in reported use for the first time (11.3% in 2016 vs. 16.0% in 2015).(14) E-cigarette use among adolescents and young adults has been associated with increased intentions to smoke and a future risk of smoking.(15–17)

Even though adolescents who have ever used e-cigarettes are less likely to be smokers than adults who have ever used e-cigarettes,(18) almost half (47.2%) of the 20.2% of high school students who reported current use of any tobacco product also reported use of two or more tobacco products, suggesting that dual use may not be uncommon.(14) In addition to conventional cigarettes, adolescent users of e-cigarettes may be more likely to use other substances, including marijuana, blunts, hookahs, and/or alcohol, but these associations may not always be consistent in different populations.(19,20)

Focus groups have described reasons for experimentation with e-cigarettes, including curiosity, appealing flavors, and peer influences.(21) Another study reported that reasons for using e-cigarettes among middle and high school students may include their low cost, the ability to use them anywhere with limited risk of detection, and smoking cessation.(22) The ease of use may translate into common locations for adolescent use of e-cigarettes, including everywhere (38%), school bathrooms (26%), home (21%), school staircases (11%), and school cafeterias (4%), based on focus group data from male high school students from the U.S. Southwest.(23)

Youth may also engage in e-cigarette use behaviors that may put them at higher risk for potential health consequences from e-cigarette use. “Dripping” is a technique through which e-liquid is dripped onto an atomizer directly resulting in a high-temperature vapor that is inhaled immediately, which may lead to higher concentrations of toxic chemicals (e.g., aldehydes).(24,25) One survey of high school ever e-cigarette users found that 26.1% had engaged in dripping.(25) E-cigarettes can also be modified or used to vaporize cannabis (hash oil, wax infused with tetrahydrocannabinol (THC), or dried cannabis leaves),(26) and in another survey, 27.9% of high school e-cigarette users reported vaporizing cannabis.(27) Youth who use e-cigarettes may also be at risk of “unintentional” nicotine exposure. In one study of middle and high school students who reported e-cigarette use within the past 30 days, 28.5% reported using e-liquid that did not contain nicotine and 37.4% reported using e-liquid with nicotine, but 34.1% were unaware of the nicotine concentration of their e-liquid.(28)

It is less clear whether youth engage in other known e-cigarette use behaviors that lead to greater exposure. For example, naive and experienced users may have different systemic exposures due to different patterns of inhalation and exhalation.(7) One study found that naive users of e-cigarettes, even those who smoke conventional cigarettes, had lower plasma nicotine levels than experienced users owing to shorter puff duration.(8) The topography of adolescent e-cigarette users, and thus risk profile based on use, is unknown. Also, while there are larger commercially available devices known as “tanks,” which operate with higher voltages resulting in vapors containing carcinogens (e.g., formaldehyde) in similar levels to conventional tobacco smoke,(29) which e-cigarette device youth tend to preferentially use are also not known. However, a majority of current adolescent e-cigarettes users (68.4%) report using flavored e-cigarettes.(30)

Health Risks of Primary Exposure to E-Cigarette

There are a few published studies regarding the short-term health effects of e-cigarette use for adolescents and young adults. Chronic bronchitic symptoms (chronic cough, phlegm, or bronchitis) are reported to be twice as common among adolescent e-cigarette users compared with never users.(31) In addition, e-cigarette use among adolescents may be associated with an increased prevalence of physician-diagnosed asthma and school absences secondary to asthma symptoms, even after adjusting for conventional cigarette use.(32) Daily e-cigarette use among middle and high school students has also been associated with self-reported oral symptoms, including cracked/broken teeth and tongue/cheek pain.(33)

Data on the long-term health effects of e-cigarettes for adolescent and young adult users are very limited owing to the limited time frame these devices have been on the market. Potential long-term effects may include cancers, nicotine dependence, and chronic lung conditions. Neoplastic risk may be associated with any of the components of e-cigarettes (i.e., nicotine, carrier agents, or flavorings). Nicotine exposure is not necessarily associated with tumor development, but it has been shown to promote tumor growth and metastasis.(34) Thus, it is possible that long-term use of e-cigarettes could increase the risk of malignancy in users with an underlying predisposition for tumor development or those who also smoke conventional cigarettes.

Known and potential carcinogens such as formaldehyde, acetaldehyde, and acrolein can be produced when carrier agents such as propylene glycol or vegetable glycerin are heated,(35) and production of these compounds may be increased with the higher temperatures associated with “dripping” or variable heating devices. Other toxins and/or carcinogens have been identified through chromatographic and spectroscopic analysis; an analysis of 12 brands of e-cigarettes detected carbonyls, volatile organic compounds, nitrosamines, and heavy metals, although in levels 9–450 times lower than those found in conventional cigarette smoke.(35) A recent study detected high but variable levels of nickel in e-cigarette solutions collected from the cartridges of several different commercial brands.(36)

Nicotine dependence is also a long-term risk with the use of e-cigarettes containing nicotine. While a recent study found that certain subgroups of adolescent smokers were more likely to become nicotine dependent,(37) it is unknown whether there exist subgroups of adolescents who are at higher risk of becoming nicotine dependent with e-cigarette use. With certain devices and experienced e-cigarette users, nicotine delivery via e-cigarettes can exceed that of combustible cigarettes.(38)

With respect to the development of permanent respiratory conditions, data from human airway cells and mice suggest that the development of features of chronic obstructive pulmonary disease (COPD) (cytokine profiles, airway hyper-reactivity, and lung architecture destruction) with exposure to e-cigarettes is possible.(39) Chronic exposure to nicotine-containing e-cigarettes in mice has been associated with decreased mucociliary clearance,(40) compared to carrier agent alone, which could predispose to recurrent infections or chronic bronchitis.

Although some e-liquid manufacturers advertise their products as made from USP (U.S. Pharmacopeial Convention) or food grade ingredients, this is based on oral consumption and the inhalational properties of the chemical compounds have not necessarily been assessed. A recent study of flavored e-cigarettes detected diacetyl in 39 of the 51 e-cigarettes tested; of note the flavoring chemical diacetyl has been associated with bronchiolitis obliterans (“popcorn lung”) in employees of microwave popcorn manufacturers.(41) A number of candy and fruit e-cigarette flavors that are appealing to youth have been shown to have cytotoxic and/or mutagenic effects in cell culture.(6)

With regard to youth perception of the risks of e-cigarette use, data from the 2014 National Youth Tobacco Survey of U.S. middle and high school students indicate that many youth view e-cigarettes as less harmful (73.0%) and less addictive (47.1%) than conventional cigarettes.(42) In this same survey, use of tobacco products by youth was associated with decreased harm perception and addictiveness.

Health Risks of Secondhand and Thirdhand Exposure to E-Cigarettes

Secondhand exposure to e-cigarette emissions may be common. One survey of parents in the U.S. Midwest reported that e-cigarette use was reported in 12.3% of households, frequently in use with conventional cigarettes as well.(43) There are limited data on the health effects for children exposed to secondhand e-cigarette emissions. In contrast to exposure to secondhand smoke from conventional cigarettes, e-cigarettes do not generate combustion by-products, and side-stream emissions are minimal.(44) In general, several studies have shown that indoor air nicotine levels and particle concentrations during e-cigarette use are higher than background levels, but lower than levels generated by conventional cigarette smoking.(44–46)

However, serum levels of the nicotine metabolite have been reported to be similar after secondhand exposures to e-cigarettes and conventional cigarettes in nonusing adults.(47) In addition, saliva and urine cotinine levels are similar among nonusing adults living with smokers versus those living with e-cigarette users.(48) Secondhand exposure to non-nicotine-containing e-cigarettes may still have risks as at least one study has measured increased particulate levels with use of e-cigarettes without nicotine versus those with nicotine.(45) Overall, the evidence indicates a measurable exposure in the environment and biomarker data confirming nicotine absorption in nonusers, but the long-term effects of exposure for children are unknown. Nevertheless, data from neonatal mice suggest that both alveolar lung and overall growth are impaired with exposure to e-cigarette emissions,(49) and exposure during early life may lead to persistent behavioral changes in adult mice.(50)

Thirdhand exposure from conventional cigarettes and/or e-cigarettes is defined as the residual emission products that deposit on surfaces, and may be involuntarily inhaled, ingested, or dermally absorbed.(51) For example, the effects of thirdhand smoke have been detected in neonatal intensive care unit (NICU) settings when mothers who smoke visit their infants who have never been home (and thus never exposed to secondhand smoke) through infant urine cotinine and surface nicotine levels.(52) Children who live with smokers also have detectable levels of nicotine on their hands.(53) With regard to e-cigarettes, nicotine can be detected on surfaces after e-cigarette use, thus constituting a potential thirdhand exposure.(54)

Health Risks of Maternal E-Cigarette Use on the Fetus

Limited data suggest that e-cigarette use among pregnant women is associated with attempts with smoking cessation and their use among pregnant smokers may be more common than FDA-approved smoking cessation therapies.(55) Although there are no data regarding the health effects of maternal e-cigarette use on human fetuses, data from animal studies may provide some correlates for nicotine exposure in utero. In utero nicotine exposure in animal studies can lead to permanent lung architectural abnormalities of not only airways and alveoli(56–58) but also of lung vasculature.(59) A number of animal studies have demonstrated that in utero nicotine exposure may lead to small effects on cognitive performance of offspring.(60) While the health effects of in utero exposure to e-cigarettes are unknown, the rapid brain, lung, and other organ development that occurs during gestation leaves these organs vulnerable to environmental pressures.

Health Risks of Exposure to E-Cigarette Solutions and Batteries

Exposure to e-cigarettes, usually unintentionally, can pose health risks, particularly as childproof caps or locks are not in universal use in the United States to prevent children accessing e-liquid.(43) A recent analysis of calls to poison centers in the United States and its territories documented 5807 phone calls between September 2010 and December 2014 with 88% involving the e-cigarette device and 12% involving e-liquid.(61,62) Adverse health effects were commonly reported (57.8% of calls where severity information was recorded).

Commonly reported effects included vomiting, nausea, and eye irritation, but at least two fatalities were associated with e-cigarette calls, including one ingestion in a child aged 0–5 years. Most pediatric exposures to e-cigarettes reported to poison centers affect children 0–5 years old (88.1% of exposures in individuals ≤20 years old). Common routes of reported exposures included ingestion (68.9%), inhalation (16.8%), ocular (8.5%), and dermal (5.9%). Suicides via oral and intravenous self-administration of e-liquid in adults have also been reported.(62–64) Finally, the lithium batteries used in many e-cigarette devices can ignite or explode, either while recharging or spontaneously, resulting in burns.(65,66) One review of the literature indicates that nearly half of these reported burns require surgical intervention.(65) One recent case report documented a cervical fracture associated with an explosion with the device in use.(67)

Healthcare Providers and E-Cigarettes

Knowledge concerning e-cigarettes among healthcare providers who provide care to pregnant women, children, and adolescents may be limited. With respect to prenatal counseling, a 2012 survey of the American College of Obstetricians and Gynecologists reported that only 5% of members felt fully informed about e-cigarettes, and of the surveyed members, 13.5% believed that they had no health effects at all.(68) With regard to parental use, only 15.3% of households where e-cigarettes were used in the home reported that their pediatrician was aware of use in one U.S. survey.(43)

A 2013 survey in Minnesota reported that 92% of healthcare providers treating adolescents were aware of e-cigarettes, but most providers (83.1%) reported knowing little to nothing about e-cigarettes.(69) In addition, many providers (65.5%) believed that e-cigarettes were safer than conventional cigarettes. A 2014 online survey of primary care providers of adolescents in the United States reported that many physicians (41%) would inform their patients that e-cigarettes are less harmful than conventional cigarettes, and some (24%) would recommend them for smoking cessation.(70) However, in a series of focus groups in another study, none of the participating pediatricians would recommend them for smoking cessation.(71) In general, few physicians (14%) have been reported to routinely screen for e-cigarette use among adolescents, but almost all (91%) support governmental regulation that prevents minors from purchasing e-cigarettes.(70)

E-Cigarette Use for Smoking Cessation

Systematic reviews and meta-analyses have not provided strong evidence that the use of e-cigarettes aids in smoking cessation over more typical cessation therapies,(72,73) or that e-cigarettes are associated with lower quit rates among smokers.(74) A 2014 survey of U.S. middle and high school students reported that e-cigarette use was not associated with a desire to quit using conventional cigarettes nor with recent quit attempts.(75) An online study of Korean students aged 13–18 years reported that e-cigarette use was associated with an attempt to quit conventional cigarettes, but that the use of e-cigarettes may have actually inhibited smoking cessation.(76) At the current time, there are no published studies on the effectiveness of e-cigarettes as a means for cessation of conventional cigarette use in adolescents.

E-Cigarette Policy Statements

A July 2014 position statement from the Forum of International Respiratory Societies, which includes the American College of Chest Physicians, the American Thoracic Society, and the European Respiratory Society among others, called for restrictions or bans on electronic nicotine delivery devices as a precaution pending the availability of additional safety data.(77) The 2015 American Academy of Pediatrics public policy statement recommended regulation of e-cigarettes, including prohibition of promotion and sales to youth, and comprehensive bans in public spaces of tobacco-related products that produce emissions.(78) A 2014 policy statement from the American Heart Association supported regulation of e-cigarettes also including prohibiting sales and marketing to minors with taxes high enough to discourage youth use.(79)

E-Cigarette Legislation

The World Health Organization's Framework Convention on Tobacco Control, a treaty signed and ratified by most nations (although notably not the United States), released a report on e-cigarettes during its seventh session in 2016.(80) Recommendations from the Framework Convention on Tobacco Control are considered to be legally binding for signatories. This report recommended that signatory parties ban the sale of e-cigarettes to minors and also recommended prohibiting the use of e-cigarettes in indoor spaces to protect bystanders from secondhand emissions.

With regard to access for minors, regulation of e-cigarettes varies widely by country as in some countries sales are completely banned (e.g., Brazil), in other countries sales of only nicotine-containing e-cigarettes are banned (e.g., Canada), in others sales to minors are prohibited (e.g., European Union and the United States), and in still others sales are unregulated, thus minors can purchase them (e.g., the Philippines). Currently, indoor bans are largely enacted by local and state jurisdictions, but there are some nationwide bans (e.g., Belgium and Spain).(81)

Conclusions

As an emerging inhalational exposure, e-cigarettes have rapidly gained public awareness with increasing use among adolescents and adults. Although the long-term health risks for primary use and secondhand emission exposure are unknown, limited data from animal studies suggest that there is the potential for long-term lung injury and altered neurocognitive development in children with exposure to nicotine-containing aerosols. Further research is needed to determine the scope of health effects associated with primary and secondhand e-cigarette exposure. Finally, public policy organizations and legislators have taken steps to restrict access of sales to youth younger than 18, and smaller steps to limit children's exposure to secondhand emissions in public areas. Likewise, pediatricians and other child healthcare providers should screen for use and exposure to e-cigarettes and be prepared to counsel on reducing or eliminating this exposure.

Acknowledgment

Drs. Collaco and McGrath-Morrow have received funding from the American Academy of Pediatrics to study the health effects of e-cigarette exposure within the past 3 years, but this funding agency has not had any role in this article. There were no funding sources for this article.

Author Disclosure Statement

No competing financial interests exist.

References

  • 1.Collaco JM, Drummond MB, and McGrath-Morrow SA: Electronic cigarette use and exposure in the pediatric population. JAMA Pediatr. 2015;169:177–182 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Farsalinos KE, Yannovits N, Sarri T, Voudris V, and Poulas K: Protocol proposal for, and evaluation of, consistency in nicotine delivery from the liquid to the aerosol of electronic cigarettes atomizers: Regulatory implications. Addiction. 2016;111:1069–1076 [DOI] [PubMed] [Google Scholar]
  • 3.Farsalinos KE, Spyrou A, Tsimopoulou K, Stefopoulos C, Romagna G, and Voudris V: Nicotine absorption from electronic cigarette use: Comparison between first and new-generation devices. Sci Rep. 2014;4:4133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Bullen C, Howe C, Laugesen M, McRobbie H, Parag V, Williman J, and Walker N: Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet. 2013;382:1629–1637 [DOI] [PubMed] [Google Scholar]
  • 5.Williams M, and Talbot P: Variability among electronic cigarettes in the pressure drop, airflow rate, and aerosol production. Nicotine Tob Res. 2011;13:1276–1283 [DOI] [PubMed] [Google Scholar]
  • 6.Chun LF, Moazed F, Calfee CS, Matthay MA, and Gotts JE: Pulmonary toxicity of e-cigarettes. Am J Physiol Lung Cell Mol Physiol. 2017;313:L193–L206 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Farsalinos KE, Romagna G, Tsiapras D, Kyrzopoulos S, and Voudris V: Evaluation of electronic cigarette use (vaping) topography and estimation of liquid consumption: Implications for research protocol standards definition and for public health authorities' regulation. Int J Environ Res Public Health. 2013;10:2500–2514 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Farsalinos KE, Spyrou A, Stefopoulos C, Tsimopoulou K, Kourkoveli P, Tsiapras D, Kyrzopoulos S, Poulas K, and Voudris V: Nicotine absorption from electronic cigarette use: Comparison between experienced consumers (vapers) and naive users (smokers). Sci Rep. 2015;5:11269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Li Q, Zhan Y, Wang L, Leischow SJ, and Zeng DD: Analysis of symptoms and their potential associations with e-liquids' components: A social media study. BMC Public Health. 2016;16:674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Goniewicz ML, Hajek P, and McRobbie H: Nicotine content of electronic cigarettes, its release in vapour and its consistency across batches: Regulatory implications. Addiction. 2014;109:500–507 [DOI] [PubMed] [Google Scholar]
  • 11.Trehy ML, Ye W, Hadwiger ME, Moore TW, Allgire JF, Woodruff JT, Ahadi SS, Black JC, and Westenberger BJ: Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Related Technol. 2011;34:1442–1458 [Google Scholar]
  • 12.Food and Drug Adminstration: Deeming tobacco products to be subject to the Federal Food, Drug, and Cosmetic Act, as amended by the Family Smoking Prevention and Tobacco Control Act; regulations on the sale and distribution of tobacco products and required warning statements for tobacco products. Fed Regist. 2014;79:23142–23207 [PubMed] [Google Scholar]
  • 13.Shihadeh A, and Eissenberg T: Electronic cigarette effectiveness and abuse liability: Predicting and regulating “Nicotine Flux”. Nicotine Tob Res. 2015;17:158–162 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Jamal A, Gentzke A, Hu SS, Cullen KA, Apelberg BJ, Homa DM, and King BA: Tobacco use among middle and high school students—United States, 2011–2016. MMWR Morb Mortal Wkly Rep. 2017;66:597–603 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Bunnell RE, Agaku IT, Arrazola R, Apelberg BJ, Caraballo RS, Corey CG, Coleman B, Dube SR, and King BA: Intentions to smoke cigarettes among never-smoking U.S. middle and high school electronic cigarette users, National Youth Tobacco Survey, 2011–2013. Nicotine Tob Res. 2015;17:228–235 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Miech R, Patrick ME, O'Malley PM, and Johnston LD: E-cigarette use as a predictor of cigarette smoking: Results from a 1-year follow-up of a national sample of 12th grade students. Tob Control. 2017. [Epub ahead of print]; DOI: 10.1136/tobaccocontrol-2016-053291 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Soneji S, Barrington-Trimis JL, Wills TA, Leventhal AM, Unger JB, Gibson LA, Yang J, Primack BA, Andrews JA, Miech RA, Spindle TR, Dick DM, Eissenberg T, Hornik RC, Dang R, and Sargent JD: Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: A systematic review and meta-analysis. JAMA Pediatr. 2017;171:788–797 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Carroll Chapman SL, and Wu LT: E-cigarette prevalence and correlates of use among adolescents versus adults: A review and comparison. J Psychiatr Res. 2014;54:43–54 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lessard J, Henrie J, Livingston JA, Leonard KE, Colder CR, and Eiden RD: Correlates of ever having used electronic cigarettes among older adolescent children of alcoholic fathers. Nicotine Tob Res. 2014;16:1656–1660 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Camenga DR, Kong G, Cavallo DA, Liss A, Hyland A, Delmerico J, Cummings KM, and Krishnan-Sarin S: Alternate tobacco product and drug use among adolescents who use electronic cigarettes, cigarettes only, and never smokers. J Adolesc Healt. 2014;55:588–591 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Kong G, Morean ME, Cavallo DA, Camenga DR, and Krishnan-Sarin S: Reasons for electronic cigarette experimentation and discontinuation among adolescents and young adults. Nicotine Tob Res. 2015;17:847–854 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bold KW, Kong G, Cavallo DA, Camenga DR, and Krishnan-Sarin S: Reasons for trying e-cigarettes and risk of continued use. Pediatrics. 2016;138: pii. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Peters RJ, Jr., Meshack A, Lin MT, Hill M, and Abughosh S: The social norms and beliefs of teenage male electronic cigarette use. J Ethn Subst Abuse. 2013;12:300–307 [DOI] [PubMed] [Google Scholar]
  • 24.Talih S, Balhas Z, Salman R, Karaoghlanian N, and Shihadeh A: “Direct Dripping”: A high-temperature, high-formaldehyde emission electronic cigarette use method. Nicotine Tob Res. 2016;18:453–459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Krishnan-Sarin S, Morean M, Kong G, Bold KW, Camenga DR, Cavallo DA, Simon P, and Wu R: E-Cigarettes and “Dripping” among high-school youth. Pediatrics. 2017;139: pii. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Malouff JM, Rooke SE, and Copeland J: Experiences of marijuana-vaporizer users. Subst Abuse. 2014;35:127–128 [DOI] [PubMed] [Google Scholar]
  • 27.Morean ME, Kong G, Camenga DR, Cavallo DA, and Krishnan-Sarin S: High school students' use of electronic cigarettes to vaporize cannabis. Pediatrics. 2015;136:611–616 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Morean ME, Kong G, Cavallo DA, Camenga DR, and Krishnan-Sarin S: Nicotine concentration of e-cigarettes used by adolescents. Drug Alcohol Depend. 2016;167:224–227 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Kosmider L, Sobczak A, Fik M, Knysak J, Zaciera M, Kurek J, and Goniewicz ML: Carbonyl compounds in electronic cigarette vapors-effects of nicotine solvent and battery output voltage. Nicotine Tob Res. 2014;16:1319–1326 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Dai H, and Hao J: Flavored electronic cigarette use and smoking among youth. Pediatrics. 2016;138 pii. [DOI] [PubMed] [Google Scholar]
  • 31.McConnell R, Barrington-Trimis JL, Wang K, Urman R, Hong H, Unger J, Samet J, Leventhal A, and Berhane K: Electronic cigarette use and respiratory symptoms in adolescents. Am J Respir Crit Care Med. 2017;195:1043–1049 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Cho JH, and Paik SY: Association between electronic cigarette use and asthma among high school students in South Korea. PLoS One. 2016;11:e0151022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Cho JH: The association between electronic-cigarette use and self-reported oral symptoms including cracked or broken teeth and tongue and/or inside-cheek pain among adolescents: A cross-sectional study. PLoS One. 2017;12:e0180506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Schaal C, and Chellappan SP: Nicotine-mediated cell proliferation and tumor progression in smoking-related cancers. Mol Cancer Res. 2014;12:14–23 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P, 3rd, and Benowitz N: Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133–139 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Hess CA, Olmedo P, Navas-Acien A, Goessler W, Cohen JE, and Rule AM: E-cigarettes as a source of toxic and potentially carcinogenic metals. Environ Res. 2017;152:221–225 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Rose JS, Lee CT, Dierker LC, Selya AS, and Mermelstein RJ: Adolescent nicotine dependence symptom profiles and risk for future daily smoking. Addict Behav. 2012;37:1093–1100 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ramoa CP, Hiler MM, Spindle TR, Lopez AA, Karaoghlanian N, Lipato T, Breland AB, Shihadeh A, and Eissenberg T: Electronic cigarette nicotine delivery can exceed that of combustible cigarettes: A preliminary report. Tob Control. 2016;25:e6–e9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Garcia-Arcos I, Geraghty P, Baumlin N, Campos M, Dabo AJ, Jundi B, Cummins N, Eden E, Grosche A, Salathe M, and Foronjy R: Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner. Thorax. 2016;71:1119–1129 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Laube BL, Afshar-Mohajer N, Koehler K, Chen G, Lazarus P, Collaco JM, and McGrath-Morrow SA: Acute and chronic in vivo effects of exposure to nicotine and propylene glycol from an E-cigarette on mucociliary clearance in a murine model. Inhal Toxicol. 2017;29:197–205 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Allen JG, Flanigan SS, LeBlanc M, Vallarino J, MacNaughton P, Stewart JH, and Christiani DC: Flavoring chemicals in e-cigarettes: Diacetyl, 2,3-pentanedione, and acetoin in a sample of 51 products, including fruit-, candy-, and cocktail-flavored e-cigarettes. Environ Health Perspect. 2016;124:733–739 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Amrock SM, Lee L, and Weitzman M: Perceptions of e-cigarettes and noncigarette tobacco products among US youth. Pediatrics. 2016;138 pii. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Garbutt JM, Miller W, Dodd S, Bobenhouse N, Sterkel R, and Strunk RC: Parental use of electronic cigarettes. Acad Pediatr. 2015;15:599–604 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Czogala J, Goniewicz ML, Fidelus B, Zielinska-Danch W, Travers MJ, and Sobczak A: Secondhand exposure to vapors from electronic cigarettes. Nicotine Tob Res. 2014;16:655–662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Ruprecht AA, De Marco C, Pozzi P, Munarini E, Mazza R, Angellotti G, Turla F, and Boffi R: Comparison between particulate matter and ultrafine particle emission by electronic and normal cigarettes in real-life conditions. Tumori. 2014;100:e24–e27 [DOI] [PubMed] [Google Scholar]
  • 46.Schober W, Szendrei K, Matzen W, Osiander-Fuchs H, Heitmann D, Schettgen T, Jorres RA, and Fromme H: Use of electronic cigarettes (e-cigarettes) impairs indoor air quality and increases FeNO levels of e-cigarette consumers. Int J Hyg Environ Health. 2014;217:628–637 [DOI] [PubMed] [Google Scholar]
  • 47.Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, Wallace Hayes A, Tsatsakis AM, and Koutedakis Y: Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol. 2013;25:91–101 [DOI] [PubMed] [Google Scholar]
  • 48.Ballbe M, Martinez-Sanchez JM, Sureda X, Fu M, Perez-Ortuno R, Pascual JA, Salto E, and Fernandez E: Cigarettes vs. e-cigarettes: Passive exposure at home measured by means of airborne marker and biomarkers. Environ Res. 2014;135C:76–80 [DOI] [PubMed] [Google Scholar]
  • 49.McGrath-Morrow SA, Hayashi M, Aherrera A, Lopez A, Malinina A, Collaco JM, Neptune E, Klein JD, Winickoff JP, Breysse P, Lazarus P, and Chen G: The effects of electronic cigarette emissions on systemic cotinine levels, weight and postnatal lung growth in neonatal mice. PLoS One. 2015;10:e0118344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Smith D, Aherrera A, Lopez A, Neptune E, Winickoff JP, Klein JD, Chen G, Lazarus P, Collaco JM, and McGrath-Morrow SA: Adult behavior in male mice exposed to e-cigarette nicotine vapors during late prenatal and early postnatal life. PLoS One. 2015;10:e0137953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Matt GE, Quintana PJ, Destaillats H, Gundel LA, Sleiman M, Singer BC, Jacob P, Benowitz N, Winickoff JP, Rehan V, Talbot P, Schick S, Samet J, Wang Y, Hang B, Martins-Green M, Pankow JF, and Hovell MF: Thirdhand tobacco smoke: Emerging evidence and arguments for a multidisciplinary research agenda. Environ Health Perspect. 2011;119:1218–1226 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Northrup TF, Khan AM, Jacob P, 3rd, Benowitz NL, Hoh E, Hovell MF, Matt GE, and Stotts AL: Thirdhand smoke contamination in hospital settings: Assessing exposure risk for vulnerable paediatric patients. Tob Control. 2016;25:619–623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Mahabee-Gittens EM, Merianos AL, and Matt GE: Preliminary evidence that high levels of nicotine on children's hands may contribute to overall tobacco smoke exposure. Tob Control. 2017. [Epub ahead of print]; DOI: 10.1136/tobaccocontrol-2016-053602 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Goniewicz ML, and Lee L: Electronic cigarettes are a source of thirdhand exposure to nicotine. Nicotine Tob Res. 2015;17:256–258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Oncken C, Ricci KA, Kuo CL, Dornelas E, Kranzler HR, and Sankey HZ: Correlates of electronic cigarettes use before and during pregnancy. Nicotine Tob Res. 2017;19:585–590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Maritz GS, and Harding R: Life-long programming implications of exposure to tobacco smoking and nicotine before and soon after birth: Evidence for altered lung development. Int J Environ Res Public Health. 2011;8:875–898 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Maritz GS, and Rayise SS: Effect of maternal nicotine exposure on neonatal rat lung development: Protective effect of maternal ascorbic acid supplementation. Exp Lung Res. 2011;37:57–65 [DOI] [PubMed] [Google Scholar]
  • 58.Miller MD, and Marty MA: Impact of environmental chemicals on lung development. Environ Health Perspect. 2010;118:1155–1164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Petre MA, Petrik J, Ellis R, Inman MD, Holloway AC, and Labiris NR: Fetal and neonatal exposure to nicotine disrupts postnatal lung development in rats: Role of VEGF and its receptors. Int J Toxicol. 2011;30:244–252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Abbott LC, and Winzer-Serhan UH: Smoking during pregnancy: Lessons learned from epidemiological studies and experimental studies using animal models. Crit Rev Toxicol. 2012;42:279–303 [DOI] [PubMed] [Google Scholar]
  • 61.Chatham-Stephens K, Law R, Taylor E, Kieszak S, Melstrom P, Bunnell R, Wang B, Day H, Apelberg B, Cantrell L, Foster H, and Schier JG: Exposure calls to U. S. Poison Centers involving electronic cigarettes and conventional cigarettes-September 2010–December 2014. J Med Toxicol. 2016;12:350–357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Chatham-Stephens K, Law R, Taylor E, Melstrom P, Bunnell R, Wang B, Apelberg B, Schier JG; Centers for Disease Control and Prevention (CDC): Notes from the field: Calls to poison centers for exposures to electronic cigarettes—United States, September 2010-February 2014. MMWR Morb Mortal Wkly Rep. 2014;63:292–293 [PMC free article] [PubMed] [Google Scholar]
  • 63.Sommerfeld K, Lukasik-Glebocka M, Kulza M, Druzdz A, Panienski P, Florek E, and Zielinska-Psuja B: Intravenous and oral suicidal e-liquid poisonings with confirmed nicotine and cotinine concentrations. Forensic Sci Int. 2016;262:e15–e20 [DOI] [PubMed] [Google Scholar]
  • 64.Thornton SL, Oller L, and Sawyer T: Fatal intravenous injection of electronic nicotine delivery system refilling solution. J Med Toxicol. 2014;10:202–204 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Harshman J, Vojvodic M, and Rogers AD: Burns associated with e-cigarette batteries: A case series and literature review CJEM. 2017:1–9. [Epub ahead of print]; DOI: 10.1017/cem.2017.32 [DOI] [PubMed] [Google Scholar]
  • 66.Rudy SF, and Durmowicz EL: Electronic nicotine delivery systems: Overheating, fires and explosions. Tob Control. 2016[Epub ahead of print]; DOI: 10.1136/tobaccocontrol-2015-052626 [DOI] [PubMed] [Google Scholar]
  • 67.Norii T, and Plate A: Electronic cigarette explosion resulting in a C1 and C2 fracture: A case report. J Emerg Med. 2017;52:86–88 [DOI] [PubMed] [Google Scholar]
  • 68.England LJ, Anderson BL, Tong VT, Mahoney J, Coleman-Cowger VH, Melstrom P, and Schulkin J: Screening practices and attitudes of obstetricians-gynecologists toward new and emerging tobacco products. Am J Obstet Gynecol. 2014;211:e1–e7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Pepper JK, McRee AL, and Gilkey MB: Healthcare providers' beliefs and attitudes about electronic cigarettes and preventive counseling for adolescent patients. J Adolesc Health. 2014;54:678–683 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Pepper JK, Gilkey MB, and Brewer NT: Physicians' counseling of adolescents regarding e-cigarette use. J Adolesc Health. 2015;57:580–586 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Gorzkowski JA, Whitmore RM, Kaseeska KR, Brishke JK, and Klein JD: Pediatrician knowledge, attitudes, and practice related to electronic cigarettes. J Adoles Health. 2016;59:81–86 [DOI] [PubMed] [Google Scholar]
  • 72.El Dib R, Suzumura EA, Akl EA, Gomaa H, Agarwal A, Chang Y, Prasad M, Ashoorion V, Heels-Ansdell D, Maziak W, and Guyatt G: Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: A systematic review and meta-analysis. BMJ Open. 2017;7:e012680. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, and Hajek P: Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev. 2016;9:CD010216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Kalkhoran S, and Glantz SA: E-cigarettes and smoking cessation in real-world and clinical settings: A systematic review and meta-analysis. Lancet Respir Med. 2016;4:116–128 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Lippert AM: Do adolescent smokers use e-cigarettes to help them quit? The sociodemographic correlates and cessation motivations of U.S. adolescent e-cigarette use. Am J Health Promot. 2015;29:374–379 [DOI] [PubMed] [Google Scholar]
  • 76.Lee S, Grana RA, and Glantz SA: Electronic cigarette use among Korean adolescents: A cross-sectional study of market penetration, dual use, and relationship to quit attempts and former smoking. J Adolesc Health. 2014;54:684–690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Schraufnagel DE, Blasi F, Drummond MB, Lam DC, Latif E, Rosen MJ, Sansores R, Van Zyl-Smit R; Forum of International Respiratory Societies: Electronic cigarettes: A position statement of the forum of international respiratory societies. Am J Respir crit Care Med. 2014;190:611–618 [DOI] [PubMed] [Google Scholar]
  • 78.Farber HJ, Nelson KE, Groner JA, Walley SC; Section on Tobacco Control: Public policy to protect children from tobacco, nicotine, and tobacco smoke. Pediatrics. 2015;136:998–1007 [DOI] [PubMed] [Google Scholar]
  • 79.Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, Robertson RM, McAuley T, Goff D, Benowitz N; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research: Electronic cigarettes: A policy statement from the American Heart Association. Circulation. 2014;130:1418–1436 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Conference of the Parties to the WHO Framework Convention on Tobacco Control: Electronic Nicotine Delivery Systems and Electronic Non-nicotine Delivery Systems (ENDS/ENNDS). World Health Organization, Delhi, India; 2016 [Google Scholar]
  • 81.Soule EK, Maloney SF, Spindle TR, Rudy AK, Hiler MM, and Cobb CO: Electronic cigarette use and indoor air quality in a natural setting. Tob Control. 2017;26:109–112 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Aerosol Medicine and Pulmonary Drug Delivery are provided here courtesy of Mary Ann Liebert, Inc.

RESOURCES